Dimensional Fund Advisors LP Organogenesis Holdings Inc. Transaction History
Dimensional Fund Advisors LP
- $391 Billion
- Q1 2025
A detailed history of Dimensional Fund Advisors LP transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 3,100,396 shares of ORGO stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,100,396
Previous 2,789,265
11.15%
Holding current value
$14 Million
Previous $8.93 Million
50.06%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ORGO
# of Institutions
141Shares Held
67.4MCall Options Held
15.3KPut Options Held
925-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$56.5 Million4.46% of portfolio
-
Morgan Stanley New York, NY12.1MShares$54.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$20.1 Million0.0% of portfolio
-
Assenagon Asset Management S.A.2.86MShares$12.9 Million0.02% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...